IL76855A0 - Spiro-heteroazolones for treatment of diabetic complications - Google Patents

Spiro-heteroazolones for treatment of diabetic complications

Info

Publication number
IL76855A0
IL76855A0 IL76855A IL7685585A IL76855A0 IL 76855 A0 IL76855 A0 IL 76855A0 IL 76855 A IL76855 A IL 76855A IL 7685585 A IL7685585 A IL 7685585A IL 76855 A0 IL76855 A0 IL 76855A0
Authority
IL
Israel
Prior art keywords
nitrogen
hydrogen
methine
alkyl
carbon atoms
Prior art date
Application number
IL76855A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL76855A0 publication Critical patent/IL76855A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IL76855A 1984-10-30 1985-10-28 Spiro-heteroazolones for treatment of diabetic complications IL76855A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1984/001767 WO1986002647A1 (en) 1984-10-30 1984-10-30 Spiro-heteroazolones for treatment of diabetes complications

Publications (1)

Publication Number Publication Date
IL76855A0 true IL76855A0 (en) 1986-02-28

Family

ID=22182314

Family Applications (1)

Application Number Title Priority Date Filing Date
IL76855A IL76855A0 (en) 1984-10-30 1985-10-28 Spiro-heteroazolones for treatment of diabetic complications

Country Status (17)

Country Link
EP (1) EP0180421B1 (xx)
JP (1) JPS61109789A (xx)
KR (1) KR870000625B1 (xx)
AT (1) ATE66228T1 (xx)
AU (1) AU553839B2 (xx)
DE (1) DE3583791D1 (xx)
DK (1) DK166150C (xx)
ES (1) ES8704168A1 (xx)
FI (1) FI83322C (xx)
GR (1) GR852606B (xx)
HU (1) HU198051B (xx)
IE (1) IE58287B1 (xx)
IL (1) IL76855A0 (xx)
PH (1) PH23491A (xx)
PL (2) PL152316B1 (xx)
PT (1) PT81382B (xx)
WO (1) WO1986002647A1 (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4537892A (en) * 1983-09-14 1985-08-27 Alcon Laboratories, Inc. Spiro-tricyclicaromatic succinimide derivatives as inhibitors of aldose reductase
US4952694A (en) * 1988-07-27 1990-08-28 Pfizer Inc. Novel resolution process for racemic spiro-hydantoins
US5006657A (en) * 1988-07-27 1991-04-09 Pfizer Inc. Intermediates in a resolution process for racemic spiro hydantoins
US5037831A (en) * 1990-05-21 1991-08-06 American Home Products Corporation Spiro-isoquinoline-pyrrolidines and analogs thereof useful as aldose reductase inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2449030A1 (de) * 1974-10-11 1976-05-20 Schering Ag Neue pyridin-derivate
CA1088945A (en) * 1976-10-18 1980-11-04 Pfizer Limited Hydantoin derivatives as therapeutic agents
US4147795A (en) * 1977-02-11 1979-04-03 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4283409A (en) * 1979-10-29 1981-08-11 Pfizer Inc. Imidazolone derivatives

Also Published As

Publication number Publication date
PL255978A1 (en) 1987-07-13
PT81382B (pt) 1987-11-30
FI83322C (fi) 1991-06-25
HUT40659A (en) 1987-01-28
PT81382A (en) 1985-11-01
DK495285D0 (da) 1985-10-29
PL152323B1 (en) 1990-12-31
FI862634A0 (fi) 1986-06-19
FI862634A (fi) 1986-06-19
PH23491A (en) 1989-08-16
EP0180421B1 (en) 1991-08-14
FI83322B (fi) 1991-03-15
GR852606B (xx) 1986-03-04
AU4916485A (en) 1986-05-08
JPS61109789A (ja) 1986-05-28
DK166150C (da) 1993-08-09
PL152316B1 (en) 1990-12-31
IE58287B1 (en) 1993-08-25
KR860003262A (ko) 1986-05-21
ES548271A0 (es) 1987-03-16
ES8704168A1 (es) 1987-03-16
KR870000625B1 (ko) 1987-03-26
DE3583791D1 (de) 1991-09-19
DK166150B (da) 1993-03-15
IE852695L (en) 1986-04-30
HU198051B (en) 1989-07-28
EP0180421A1 (en) 1986-05-07
WO1986002647A1 (en) 1986-05-09
DK495285A (da) 1986-05-01
AU553839B2 (en) 1986-07-31
ATE66228T1 (de) 1991-08-15

Similar Documents

Publication Publication Date Title
CA2029420A1 (en) Pharmaceutical compositions and methods for inhibition of maillard's reaction
IL89475A0 (en) Biocidal composition comprising imidazole compounds
HK1012341A1 (en) Pyrrolocarbazole
ZA887978B (en) N-phenylalkylbenzamide fungicides
IL76855A0 (en) Spiro-heteroazolones for treatment of diabetic complications
ES8606295A1 (es) Un procedimiento para la preparacion de nuevas espiro-3-heteroazolidindionas.
DE3479419D1 (en) Aldose reductase inhibiting 5-(2-alkoxyphenyl)thiazolidinediones
AU3022489A (en) New medical use for an isocarbacyclin derivative
AU6101890A (en) Therapeutic agents for the treatment of peptic ulcer disease
DE3362523D1 (en) Optically active imidazolylpropanol compounds, and their production and use
EP0254049A3 (en) Herbicidal compositions
AU9111482A (en) 2,4,6-triamino-5-nitro pyrimidines
HUT58080A (en) Process for producing imidazole derivatives
ES8504763A1 (es) Procedimiento para preparar 4-(sustituida alquil)-n-(1,3-ditiolan-2-ilideno)anilina.
IE872998L (en) 4-hydroxy-4-(substituted alkenyl)- cyclohexanecarboxylic¹acids

Legal Events

Date Code Title Description
RH Patent void